How has Thermo Fisher Scientific's other noncash income (expense) changed year-over-year?

Thermo Fisher Scientific's other noncash income (expense) increased by 827.0% year-over-year, from -$63M to $458M.

What is the long-term trend for Thermo Fisher Scientific's other noncash income (expense)?

Over 3 years (2022 to 2025), Thermo Fisher Scientific's other noncash income (expense) has grown at a -6.1% compound annual growth rate (CAGR), from -$550M to -$455M.

Thermo Fisher Scientific TMO Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

IlluminaILMN

——

Other financials

Income statement

See full

Revenue$12.0B—

Operating income$2.1B—

Net income$1.7B+7.4%

EPS (diluted)$4.68+9.3%

Balance sheet

See full

Cash & equivalents$4.1B-11.7%

Total debt$39.2B+4.6%

Total equity$52.7B+4.3%

Total assets$113.17B+11.8%

Cash flow

See full

Operating cash flow$2.1B+51.9%

CapEx-$1.2B-509%

Free cash flow$923.0M-16.5%

Valuation

See full

Market cap$214.21B+17.7%

Enterprise value$249.32B+16.0%

P/E30.8×+3.1×

P/S4.8×-0.9×

Profitability

See full

Gross margin58.3%—

Operating margin17.2%+0.8pp

Net margin15.2%+1.0pp

FCF margin15.7%-2.1pp

Returns & leverage

See full

Return on equity13.5%+0.1pp

Debt / equity0.7×0.0×

Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Thermo Fisher Scientific’s 8-K, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Thermo Fisher Scientific's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Thermo Fisher Scientific's other noncash income (expense)?: Thermo Fisher Scientific (TMO) reported other noncash income (expense) of $458M in Q2 2026.
How has Thermo Fisher Scientific's other noncash income (expense) changed year-over-year?: Thermo Fisher Scientific's other noncash income (expense) increased by 827.0% year-over-year, from -$63M to $458M.
What is the long-term trend for Thermo Fisher Scientific's other noncash income (expense)?: Over 3 years (2022 to 2025), Thermo Fisher Scientific's other noncash income (expense) has grown at a -6.1% compound annual growth rate (CAGR), from -$550M to -$455M.